2008 Archive

ANN ARBOR, Mich., August 4, 2008 — Lycera Corporation today announced that it entered into a licensing agreement with a leading specialty pharmaceutical company in the United States to develop and commercialize a series of novel small molecules for the topical treatment of human dermal conditions, including mild to moderate psoriasis. According to the National… Read More